Patents Assigned to Altea Therapeutics Corporation
  • Patent number: 8116860
    Abstract: A transdermal permeant delivery system for delivery of at least one permeant composition into a tissue membrane of a subject including a disposable substrate having at least a portion of a bottom surface of a first release liner connected to an upper surface of the substrate and a patch having a backing layer and a reservoir that is selectively removable from the top surface of the first release liner. In a connected position, a first portion of the backing layer of the patch is releaseably mounted to a top surface of the first release liner in spaced registration with a poration area of the substrate.
    Type: Grant
    Filed: January 22, 2008
    Date of Patent: February 14, 2012
    Assignee: Altea Therapeutics Corporation
    Inventors: Bernadette Messier, Zoran Novakovic, Jeremiah Peter O'Leary, Regina Spiehl, Wendy E. Bowerman, Stephen Wilson Braun, Jonathan Eppstein, David Farquhar, Mark James Fisher, Uros Kascak, Erin Koch Henkel, Loren J. Lantz, Stuart McRae
  • Patent number: 8016811
    Abstract: A method for delivering permeant substances transdermally into a membrane of an animal includes forming at least one delivery opening in the skin tissue, with the at least one delivery opening having a mean opening depth of between about 40 and about 90 microns.
    Type: Grant
    Filed: October 24, 2003
    Date of Patent: September 13, 2011
    Assignee: Altea Therapeutics Corporation
    Inventors: Alan Smith, Jonathan A. Eppstein, Bernadette Messier, Zoran Novakovic, Stuart McRae
  • Patent number: 7758561
    Abstract: A method of enhancing the permeability of a biological membrane, including the skin or mucosa of an animal or the outer layer of a plant to a permeant is described utilizing microporation of selected depth and optionally one or more of sonic, electromagnetic, mechanical and thermal energy and a chemical enhancer. Microporation is accomplished to form a micropore of selected depth in the biological membrane and the porated site is contacted with the permeant. Additional permeation enhancement measures may be applied to the site to enhance both the flux rate of the permeant into the organism through the micropores as well as into targeted tissues within the organism.
    Type: Grant
    Filed: February 6, 2004
    Date of Patent: July 20, 2010
    Assignee: Altea Therapeutics Corporation
    Inventor: Jonathan A. Eppstein
  • Patent number: 7392080
    Abstract: The invention provides for a transdermal drug delivery device for forming a drug delivery patch system comprising: a) an actuator comprising: i) an outer body defining a top of the actuator, the outer body containing a cavity; ii) a controller board comprising driving electronics and a battery, the controller board being positioned within the cavity; and iii) an interface connection port for receiving a porator array, the interface connection port containing an anode and a cathode; b) the porator array comprising: i) a top surface, with a removable adhesive attached to the top surface, the top surface containing two concentric electrical contact rings for contacting the interface connection port at the anode and the cathode upon removal of the adhesive layer; ii) a bottom surface comprising a tissue interface membrane, the tissue interface membrane further comprising a substrate with at least one porator contained on or within the substrate, the bottom surface further comprising an adhesive layer for a
    Type: Grant
    Filed: March 11, 2003
    Date of Patent: June 24, 2008
    Assignee: Altea Therapeutics Corporation
    Inventors: Jonathan Eppstein, Stuart McRae, Alan Smith
  • Patent number: 7141034
    Abstract: A transdermal drug delivery device for forming a micropore in a tissue membrane of an animal comprising a substrate and a porator that is located on or within the substrate. The porator is constructed of a material that is destroyed upon forming the micropore. The transdermal drug delivery device also comprises at least one reservoir and a controller for controlling the formation of said micropore by the porator and destroying the porator after the formation of the micropore.
    Type: Grant
    Filed: March 11, 2003
    Date of Patent: November 28, 2006
    Assignee: Altea Therapeutics Corporation
    Inventors: Jonathan Eppstein, Stuart McRae, Joseph Papp
  • Patent number: 6922578
    Abstract: An integrated device for poration of biological tissue, harvesting a biological fluid from the tissue, and analysis of the biological fluid. The device comprises a tissue-contacting layer having an electrically or optically heated probe to heat and conduct heat to the tissue to form at least one opening, such as a micropore to collect biological fluid from the opening, and a detecting layer responsive to the biological fluid to provide an indication of a characteristic of the biological fluid, such as the concentration of an analyte in interstitial fluid. In the embodiment in which, the probe comprises a photosensitizing assembly designed for the uniform application of a photosensitizing material, such as, for example, a dye or a pigment, to a tissue, e.g., the stratum comeum.
    Type: Grant
    Filed: September 25, 2003
    Date of Patent: July 26, 2005
    Assignees: SpectRx, Inc., Altea Therapeutics Corporation
    Inventors: Jonathan A. Eppstein, Mark A. Samuels, Michael R. Hatch
  • Publication number: 20040220456
    Abstract: A method of enhancing the permeability of a biological membrane, including the skin or mucosa of an animal or the outer layer of a plant to a permeant is described utilizing microporation of selected depth and optionally one or more of sonic, electromagnetic, mechanical and thermal energy and a chemical enhancer. Microporation is accomplished to form a micropore of selected depth in the biological membrane and the porated site is contacted with the permeant. Additional permeation enhancement measures may be applied to the site to enhance both the flux rate of the permeant into the organism through the micropores as well as into targeted tissues within the organism.
    Type: Application
    Filed: February 6, 2004
    Publication date: November 4, 2004
    Applicant: Altea Therapeutics Corporation
    Inventor: Jonathan A. Eppstein
  • Patent number: 6730028
    Abstract: A method and device for forming artificial openings in a biological membrane with a pyrotechnic charge that is exploded in a controlled manner in proximity of the biological membrane to form the artificial opening(s) therein. The method and device are useful in connection with transdermal delivery and monitoring applications.
    Type: Grant
    Filed: October 29, 2001
    Date of Patent: May 4, 2004
    Assignee: Altea Therapeutics Corporation
    Inventors: Jonathan A. Eppstein, Michael R. Hatch, Joseph Papp, Mark L. Faupel, Krishna Kumar
  • Patent number: 6692456
    Abstract: The invention provides for improved devices and methods for forming openings in a biological membrane for delivering substances into an animal through the biological membrane for treatment applications, or extracting substances from the animal through the biological membrane for monitoring or other diagnosis applications and for increased transmembrane flux.
    Type: Grant
    Filed: June 8, 2000
    Date of Patent: February 17, 2004
    Assignee: Altea Therapeutics Corporation
    Inventors: Jonathan A. Eppstein, Michael R. Hatch, Joseph Papp
  • Patent number: D574500
    Type: Grant
    Filed: May 19, 2006
    Date of Patent: August 5, 2008
    Assignee: Altea Therapeutic Corporation
    Inventors: Erin Melissa Koch, Mark James Fisher, Jeremiah Peter O'Leary, Stephen Wilson Braun, Uros Kascak, Loren J. Lantz, Zoran Novakovic
  • Patent number: D605775
    Type: Grant
    Filed: July 24, 2008
    Date of Patent: December 8, 2009
    Assignee: Altea Therapeutics Corporation
    Inventors: Erin Melissa Koch, Mark James Fisher, Jeremiah Peter O'Leary, Stephen Wilson Braun, Uros Kascak, Loren J. Lantz, Zoran Novakovic